Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable‐risk acute myeloid leukemia

Overview of attention for article published in American Journal of Hematology, December 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

policy: 1 policy source

twitter: 1 X user

Readers on

mendeley: 27 Mendeley

So far, Altmetric has seen 1 X post from an account with 925 followers.

New article: Outcomes of Therapy with Venetoclax Combined with A Hypomethylating Agent in Favorable-Risk Acute Myeloid Leukemia. https://t.co/tykj89MF2v #AML #leusm #hematology https://t.co/eUPX0D82x6

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.